CD1-MR1 2025 Leonid Metelitsa
Baylor College of Medicine, TEXAS, United States
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Cancer Immunotherapy with CAR-Redirected NKT Cells (#61)
11:55 AM
Leonid Metelitsa
Therapy of Cancer and Other Diseases 1
Allogeneic NKT Cells Expressing a CD19-specific CAR in Patients with Relapsed or Refractory B cell Malignancies: an Interim Analysis (#130)
5:02 PM
Leonid Metelitsa
Poster Session 1